Technical Analysis for CMTA - Clementia Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 16.61 -0.06% -0.01
CMTA closed down 0.06 percent on Wednesday, January 17, 2018, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
0 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical CMTA trend table...

Date Alert Name Type % Chg
Jan 17 50 DMA Resistance Bearish 0.00%
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 17 NR7 Range Contraction 0.00%
Jan 17 NR7-2 Range Contraction 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 16 50 DMA Resistance Bearish -0.06%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.06%
Jan 16 NR7 Range Contraction -0.06%
Jan 16 Inside Day Range Contraction -0.06%
Jan 16 Wide Bands Range Expansion -0.06%

Older signals for CMTA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. Its lead product candidate, palovarotene, is an oral small molecule that binds and activates retinoic acid receptor gamma (an RARg agonist), and has activity in preventing abnormal new bone formation as well as scar tissue formation (or fibrosis) in a variety of tissues in animal models. It is developing palovarotene for the treatment of Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma (MO). Its programs focus on diseases involving tissue transformation via retinoic acid receptors (RARs). The Company also has an eye drop formulation of palovarotene that can potently increase tear production and decrease corneal damage.
Is CMTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.15
52 Week Low 15.05
Average Volume 50,193
200-Day Moving Average 0.0
50-Day Moving Average 17.0672
20-Day Moving Average 17.842
10-Day Moving Average 16.741
Average True Range 0.94
ADX 26.99
+DI 15.64
-DI 21.18
Chandelier Exit (Long, 3 ATRs ) 17.33
Chandelier Exit (Short, 3 ATRs ) 18.38
Upper Bollinger Band 20.4042
Lower Bollinger Band 15.2798
Percent B (%b) 0.26
BandWidth 28.720995
MACD Line -0.2158
MACD Signal Line 0.0211
MACD Histogram -0.2369
Fundamentals Value
Market Cap 507.05 Million
Num Shares 30.5 Million
EPS -472.48
Price-to-Earnings (P/E) Ratio -0.04
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.51
Resistance 3 (R3) 17.58 17.36 17.36
Resistance 2 (R2) 17.36 17.13 17.32 17.31
Resistance 1 (R1) 16.98 16.99 16.87 16.91 17.26
Pivot Point 16.76 16.76 16.70 16.72 16.76
Support 1 (S1) 16.38 16.53 16.27 16.31 15.96
Support 2 (S2) 16.16 16.39 16.12 15.91
Support 3 (S3) 15.78 16.16 15.86
Support 4 (S4) 15.71